References
- Jensen K B, Axel E, Dam K, et al. Hjememedicin - en bog om den giftige medicin. Amalie-Galebevsgelsens Forlag, Copenhagen 1988; 5–240
- Wulff H R, Pedersen S A, Rosenberg R. Medicinsk filosofi. Munksgaard, Copenhagen 1990
- Wulff H R. Rational diagnosis and treatment. Blackwell, Oxford 1990
- Nielsen N H, Hansen A M, Poulsen J W. Idékatalog. Kvalitetssikring og referenceprogram. Sundhedsstyrelsen & Sundhedsmini-steriet, Copenhagen 1991
- Sundhedsministeriet. Forskning på mennesket. Etik/Jura. Statens Informationstje-neste, Copenhagen 1989
- Poulsen J H. Vejledning for terapeut og labora-torium. Psykiatrisk Hospital i Aarhus, Aarhus 1991
- Gram L F. Inadequate dosing and pharmacokinetic variability as confounding factors in assessment of efficacy of antidepressants. Clin Neuropharmacol 1990; 13: 35–44
- Schou M. Lithiumbehandling af manio-depressiv sygdom. Welner & Rygaard, Copenhagen 1991
- Hansen L B, Larsen N-E. Therapeutic advantages of monitoring plasma concentrations of perphenazine in clinical practice. Psychopharmacology 1985; 87: 16–9
- Putten T V, Marder S R, Wirshing W C, Aravagiri M, Chabert N. Neuroleptic plasma levels. Schizophr Bull 1991; 2: 197–216
- Baldessarini R J, Cohen B M, Teicher M H. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychosis. Arch Gen Psychiatry 1988; 45: 79–94
- Kragh-Sørensen P. Monitoring plasma concentration of nortriptyline. Lageforenin-gens Forlag, Copenhagen 1984
- Bech P. Quality of life in psychosomatic research. Psychopathology 1987; 20: 169–79
- Dansk Psykiatrisk Selskab. Brug af neuroleptika. Dansk Psykiatrisk Selskab, Copenhagen 1989
- Benzodiazepine dependence, toxicity, and abuse. A Task Force report of the American Psychiatric Association. American Psychiatric Association, Washington, DC 1990
- Beckmann H, Laux G. Guidelines for the dosage of antipsychotic drugs. Acta Psychiatr Scand 1990; 82: 63–6
- McClelland H A, Harrison G, Soni S D. Brief intermittent neuroleptic prophylaxis for selected schizophrenic out-patients. Br J Psychiatry 1989; 155: 702–6
- Nagy L M, Krystal J H, Woods S W, Charney D S. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. Arch Gen Psychiatry 1989; 46: 993–9
- Skyum O, Dahlgaard J J. Kvalitet, Danmarks fremtid. Centrum, Aarhus 1990